Purchases and Sales Made in Q2 2024 in Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS) during Q2 2024. The information is specifically focused on institutions that hold shares of Tarsus Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 09, 2024
Q2 2024
|
Quantbot Technologies LP
New York, NY |
SELL
|
- |
-581- 5.16% |
$14.6K - $22.5K
|
10.7K
$574K
|
|
Aug 08, 2024
Q2 2024
|
Envestnet Asset Management Inc
|
SELL
|
- |
-692- 6.16% |
$17.4K - $26.8K
|
10.5K
$566K
|
|
Jul 26, 2024
Q2 2024
|
Cambridge Investment Research Advisors, Inc.
|
SELL
|
- |
-1.68K- 6.8% |
$42.2K - $64.9K
|
23K
$1.24M
|
|
Jul 19, 2024
Q2 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-2.13K- 32.42% |
$53.6K - $82.5K
|
4.44K
$239K
|
|
Jul 25, 2024
Q2 2024
|
Calamos Advisors LLC
|
SELL
|
- |
-2.47K- 25.05% |
$62.3K - $95.8K
|
7.4K
$398K
|
|
Aug 14, 2024
Q2 2024
|
Aquatic Capital Management LLC
Chicago, IL |
SELL
|
- |
-2.5K- 34.72% |
$62.9K - $96.8K
|
4.7K
$253K
|
|
Aug 14, 2024
Q2 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-2.7K- 26.5% |
$68K - $105K
|
7.49K
$403K
|
|
Aug 13, 2024
Q2 2024
|
Baird Financial Group, Inc.
Milwaukee, WI |
SELL
|
- |
-4.49K- 3.5% |
$113K - $174K
|
124K
$6.65M
|
|
Aug 12, 2024
Q2 2024
|
Ieq Capital, LLC
|
SELL
|
- |
-5K- 28.16% |
$126K - $194K
|
12.8K
$686K
|
|
Aug 13, 2024
Q2 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-6.14K- 14.95% |
$154K - $238K
|
34.9K
$1.88M
|
|
Jul 12, 2024
Q2 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-6.81K- 63.81% |
$171K - $264K
|
3.86K
$208K
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-8.18K- 27.0% |
$206K - $317K
|
22.1K
$1.19M
|
|
Aug 14, 2024
Q2 2024
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-9.99K- 50.13% |
$251K - $387K
|
9.94K
$534K
|
|
Aug 14, 2024
Q2 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-10.2K- 17.51% |
$257K - $396K
|
48.1K
$2.59M
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-10.4K- 27.04% |
$261K - $402K
|
28K
$1.5M
|
|
Jul 26, 2024
Q2 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-11.2K- 5.84% |
$283K - $435K
|
181K
$9.73M
|
|
Aug 13, 2024
Q2 2024
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-11.5K- 35.07% |
$290K - $446K
|
21.3K
$1.14M
|
|
Aug 09, 2024
Q2 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-11.7K- 12.08% |
$295K - $454K
|
85.3K
$4.59M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-11.8K- 5.38% |
$297K - $457K
|
207K
$11.2M
|
|
Aug 02, 2024
Q2 2024
|
Td Asset Management Inc
|
SELL
|
- |
-13.2K- 27.17% |
$332K - $511K
|
35.4K
$1.9M
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-17.9K- 4.22% |
$451K - $694K
|
407K
$21.9M
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-33.2K- 62.3% |
$836K - $1.29M
|
20.1K
$1.08M
|
|
Jul 19, 2024
Q2 2024
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
SELL
|
- |
-37.9K- 74.43% |
$955K - $1.47M
|
13K
$700K
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-56.4K- 16.22% |
$1.42M - $2.18M
|
291K
$15.7M
|
|
Aug 14, 2024
Q2 2024
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-65K- 21.67% |
$1.64M - $2.52M
|
235K
$12.6M
|
|
Aug 13, 2024
Q2 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-134K- 18.35% |
$3.36M - $5.17M
|
594K
$32M
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-197K- 72.26% |
$4.96M - $7.63M
|
75.6K
$4.06M
|
|
Aug 15, 2024
Q2 2024
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-200K- 11.19% |
$5.03M - $7.75M
|
1.59M
$85.3M
|
|
Aug 14, 2024
Q2 2024
|
Tcg Crossover Management, LLC
Palo Alto, CA |
SELL
|
- |
-238K- 29.92% |
$5.98M - $9.2M
|
556K
$29.9M
|
|
Aug 14, 2024
Q2 2024
|
Boone Capital Management LLC
Atlanta, GA |
SELL
|
- |
-393K- 64.53% |
$9.89M - $15.2M
|
216K
$11.6M
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-420K- 95.43% |
$10.6M - $16.3M
|
20.1K
$1.08M
|
|
Aug 14, 2024
Q2 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-428K- 14.95% |
$10.8M - $16.6M
|
2.44M
$131M
|
|
Aug 14, 2024
Q2 2024
|
Healthcare Of Ontario Pension Plan Trust Fund
Toronto, A6 |
SELL
|
- |
-508K- 56.61% |
$12.8M - $19.7M
|
390K
$20.9M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-514K- 21.44% |
$12.9M - $19.9M
|
1.88M
$101M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-514K- 21.44% |
$12.9M - $19.9M
|
1.88M
$101M
|
|
Aug 14, 2024
Q2 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-1.64M- 76.63% |
$41.3M - $63.5M
|
500K
$26.9M
|